Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma
Authors
Keywords
biliary tract carcinoma, K-RAS mutation, target therapy, MEK inhibitor, preclinical models
Journal
Oncotarget
Volume 7, Issue 32, Pages -
Publisher
Impact Journals, LLC
Online
2016-07-14
DOI
10.18632/oncotarget.10587

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.